Xencor (XNCR) Change in Accured Expenses (2013 - 2026)

Xencor's (XNCR) quarterly Change in Accured Expenses came in at -$707000.0 in Q1 2026, up 77.58% year-on-year from -$398121.4 in Q1 2025, and down 110.18% on a QoQ basis from $6.9 million in Q4 2025.

Xencor (XNCR) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Change in Accured Expenses data on file, last reported at -$707000.0 in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 77.58% year-over-year to -$707000.0 in Q1 2026; TTM through Mar 2026 was $16.2 million, a 531.53% increase from a year earlier, with the FY2025 full-year figure at $13.8 million, up 417.37% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$707000.0, down from $6.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for XNCR reached as high as $6.9 million in Q4 2025 and fell as low as -$10.1 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $756647.1 across 5 years, with a median of $2.9 million in 2022.
  • Across the five-year window, Change in Accured Expenses sank 581.72% in 2024 and surged 212.15% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$561000.0 in 2022, then tumbled by 61.85% to -$908000.0 in 2023, then sank by 581.72% to -$6.2 million in 2024, then jumped by 212.15% to $6.9 million in 2025, then tumbled by 110.18% to -$707000.0 in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$707000.0 in Q1 2026, $6.9 million in Q4 2025, and $4.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 Xencor 1.49 Bn 1.11 Bn - -707,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -707,000.00
Mar 31, 2026 -707,000.00
Dec 31, 2025 6.94 Mn
Dec 31, 2025 6.94 Mn
Sep 30, 2025 4.22 Mn
Sep 30, 2025 4.22 Mn
Jun 30, 2025 5.79 Mn
Jun 30, 2025 5.79 Mn
Mar 31, 2025 -3.15 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 -6.19 Mn
Dec 31, 2024 -6.19 Mn
Sep 30, 2024 5.85 Mn
Sep 30, 2024 5.85 Mn
Jun 30, 2024 6.07 Mn
Jun 30, 2024 6.07 Mn
Mar 31, 2024 -10.07 Mn
Mar 31, 2024 -10.07 Mn
Dec 31, 2023 -908,000.00
Dec 31, 2023 -908,000.00